2460-87-9

Basic information

• Product Name: 4-TERT-BUTOXYPHENOL
• Synonyms: HYDROQUINONE MONO-TERT-BUTYL ETHER;4-TERT-BUTOXYPHENOL;4-T-butoxyphenol;Hydroquinone tert-butyl ether;4-tert-Butoxyphenol;4-(tert-Butoxy)
• CAS NO: 2460-87-9
• Molecular Formula: C₁₀H₁₄O₂
• Molecular Weight: 166.22
• Product Categories: API intermediates
• Mol File: 2460-87-9.mol

Chemical Properties

• Melting Point: 157-159°C
• Boiling Point: 263.7°Cat760mmHg
• Flash Point: 114.4°C
• Appearance: /
• Density: 1.029g/cm³
• Vapor Pressure: 0.00621mmHg at 25°C
• Refractive Index: 1.514
• PKA: 10.37±0.15(Predicted)
• CAS DataBase Reference: 4-TERT-BUTOXYPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-TERT-BUTOXYPHENOL(2460-87-9)
• EPA Substance Registry System: 4-TERT-BUTOXYPHENOL(2460-87-9)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 2460-87-9(Hazardous Substances Data)

Usage

Uses

Used in Polymer and Plastics Industry:
4-Tert-Butoxyphenol is used as a stabilizer and antioxidant for [application reason] to inhibit the degradation of polymers caused by heat, light, and oxidation, ensuring the durability and longevity of plastic products and materials.
Used in Pharmaceutical Industry:
4-Tert-Butoxyphenol is used as an intermediate in the production of pharmaceuticals for [application reason] to contribute to the synthesis of various medicinal compounds.
Used in Chemical Industry:
4-Tert-Butoxyphenol is used as an intermediate in the production of other chemicals for [application reason] to facilitate the creation of a wide range of chemical products.
Used in Personal Care Products:
4-Tert-Butoxyphenol is used as a fragrance ingredient in various personal care products for [application reason] to provide a pleasant scent and enhance the sensory experience of the products.

InChI:InChI=1/C10H14O2/c1-10(2,3)12-9-6-4-8(11)5-7-9/h4-7,11H,1-3H3

Upstream product

• 123-31-9 hydroquinone 
• 75-65-0 tert-butyl alcohol 
• 5419-55-6 Triisopropyl borate 
• 1634-04-4 tert-butyl methyl ether 
• 18995-35-2 4-tert-butoxychlorobenzene 
• 106-41-2 4-bromo-phenol 

Downstream Products

• 142346-91-6 2-[4-(1,1-dimethylethoxy)phenoxy]ethyl bromide 
• 548764-02-9 methyl-phenyl-carbamic acid 4-tert-butoxy-phenyl ester 
• 87789-44-4 4-(5'-nitropyrid-2'-yloxy)phenyl tert.-butyl ether 
• 87789-45-5 4-(5'-iodopyrid-2'-yloxy)phenyl tert.-butyl ether 
• 942056-53-3 C₁₉H₁₉F₁₃O₂ 
• 942056-54-4 C₂₁H₁₉F₁₇O₂ 
• 1071967-81-1 C₁₇H₁₉F₉O₂ 
• 65372-02-3 2-methyl-(3,4,6-tri-O-benzyl-1,2-dideoxy-α-D-glucopyrano)-<2,1-d>-2-oxazoline 
• 121123-45-3 3,4,6-tri-O-benzyl-2-acetamido-2-deoxyamino-α-D-glucopyranose 
• 1418287-63-4 methyl 4-(3-ethoxyphenyl)-1-[2-(4-hydroxyphenoxy)ethyl]-1H-pyrrolo[3,2-c]pyridine-2-carboxylate 

Relevant articles and documents

Copper-Catalyzed Hydroxylation of (Hetero)aryl Halides under Mild Conditions

The combination of Cu(acac)2 and N,N′-bis(4-hydroxyl-2,6-dimethylphenyl)oxalamide (BHMPO) provides a powerful catalytic system for hydroxylation of (hetero)aryl halides. A wide range of (hetero)aryl chlorides bearing either electron-donating or -withdrawing groups proceeded well at 130 °C, delivering the corresponding phenols and hydroxylated heteroarenes in good to excellent yields. When more reactive (hetero)aryl bromides and iodides were employed, the hydroxylation reactions completed at relatively low temperatures (80 and 60 °C, respectively) at low catalytic loadings (0.5 mol % Cu).

Sulfonic acid functionalized MCM-41 as solid acid catalyst for tert-butylation of hydroquinone enhanced by microwave heating

Covalently linked sulfonic acid (SO3H) modified MCM-41 mesoporous catalysts was prepared, characterized and its catalytic activity under microwave irradiation was evaluated. The NH2-MCM-41 was first prepared by anchoring (3-aminoprop

Angiotensin II antagonists

This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.

Angiotensin II antagonist intermediates

This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.

Angiotensin II antagonists

This invention provides novel phenyl and heterocyclic derivatives, their pharmaceutical formulations and their methods of use for antagonizing angiotensin II receptors in mammals.